Boston Scientific Acquires SVG Embolic Protection At Reduced Cost
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal with Rubicon Medical will enable commercialization of the firm's Rubicon Filter saphenous vein graft debris device; the agreement includes milestone payments upon FDA clearance.